Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility
Katie Witkiewitz, Kimber Saville, Kacie HamreusDepartment of Psychology, Washington State University Vancouver, Vancouver, WA, USAAbstract: Acamprosate, or N-acetyl homotaurine, is an N-methyl-D-aspartate receptor modulator approved by the Food and Drug Administration (FDA) as a pharmacological trea...
Main Authors: | Witkiewitz K, Saville KA, Hamreus K |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-02-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/acamprosate-for-treatment-of-alcohol-dependence-mechanisms-efficacy-an-a9178 |
Similar Items
-
Safety and Efficacy of Acamprosate for the Treatment of Alcohol Dependence
by: Stephanie L. Yahn, et al.
Published: (2013-01-01) -
Safety and Efficacy of Acamprosate for the Treatment of Alcohol Dependence
by: Stephanie L. Yahn, et al.
Published: (2013-01-01) -
Acamprosate for alcohol dependence
by: Susanne Rösner, et al. -
Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects
by: David J. Hinton, et al.
Published: (2017-05-01) -
The control of abstinence in the treatment of alcohol dependence: the use of acamprosate in relapse prevention
by: Fabio Venturella, et al.
Published: (2014-01-01)